Primary Ureteric Diffuse Large B‐Cell Lymphoma (Non‐GCB Subtype) Presenting as Obstructive Uropathy: A Rare Case Report

Read full text Summarise with VIRAT
Authors: Nisha Sharma, Bibek Shrestha, Bishal Panthi, Shovana Thapa Karki, Pradeep Raj Regmi, Alina Karna
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Primary ureteric lymphoma is an exceptionally rare extranodal manifestation of non‐Hodgkin lymphoma and often mimics more common ureteric malignancies. Diffuse large B‐cell lymphoma (DLBCL), particularly the nongerminal center B‐cell (non‐GCB) subtype with triple‐expressor phenotype, is associated with aggressive biological behavior and poorer prognosis. Case Presentation A 60‐year‐old female presented with right‐sided flank pain, oliguria, and intermittent vomiting for 8 days. Clinical evaluation revealed bilateral hydronephrosis, and imaging demonstrated periureteric soft‐tissue masses encasing the distal ureters and pelvic vessels, causing obstructive uropathy. Differential diagnoses included urothelial carcinoma and lymphoma. CT‐guided ureteric biopsy showed diffuse infiltration by atypical lymphoid cells positive for CD45, CD20, CD30, MUM1, PAX5, BCL6, c‐MYC (45%), and BCL2, with a high Ki‐67 index (~98%). The tumor cells were negative for CD10, cytokeratin, and GATA3, confirming DLBCL, non‐GCB subtype, with a triple‐expressor phenotype. PET‐CT staging showed disease confined to the ureteric segments, with no systemic nodal or extranodal involvement, supporting a primary ureteric origin. Bilateral double‐J stenting was performed to relieve obstruction and stabilize renal function, followed by six cycles of R‐CHOP chemoimmunotherapy. The patient demonstrated marked clinical and biochemical improvement, with normalization of renal function and no evidence of recurrence at 6 months of follow‐up. Conclusion This case highlights the importance of considering primary ureteric lymphoma in the differential diagnosis of atypical ureteric masses, especially with bilateral involvement. Early histopathological confirmation and prompt initiation of systemic therapy can result in favorable outcomes, even in aggressive molecular subtypes. Multidisciplinary evaluation and timely decompression are essential to optimize renal recovery and treatment tolerance.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment CNS Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders

Publication details

Journal / source
Case Reports in Oncological Medicine
Volume
2026
Issue
1
Publication date
1 January 2026
Language
EN